[Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 3. Results of tolerance tests].
N. H. K. Kiesselbach
Jonathan D. Lehnert
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
A Novel Class of Antidiabetic Agents
Lisa Brown • Sep 06, 2017
Optimizing Early Phase Antidiabetic Drug Development
Clayton A. Dehn + 2 • Apr 19, 2017
The effect of co-morbidity on the use of antidiabetics and medications for associated cardiovascular risks in Australian veterans with diabetes
Ying Zhang + 6 • Oct 10, 2017